Document is current
Any future updates will be listed below
-
Authors
Ahmed, Areeba
Koza, Eric
Shi, Victoria
Ma, Melissa
Haq, Misha
Kottner, Jan
Garg, Amit
Ingram, John R.
Ezzedine, Khaled
Spuls, Phyllis I.
Beeckman, Dimitri
Wolkenstein, Pierre
Fransen, Frederike
Noe, Megan H.
Langbroek, Ginger Beau
Bauer, Andrea
Thorlacius, Linnea
Horbach, Sophie E. R.
Layton, Alison
Apfelbacher, Christian
Cahn, Brian A.
Pearlman, Ross
Schlessinger, Daniel I.
Alam, Murad
- License Information
-
More Information
Article History
Received: 4 December 2023
Revised: 4 December 2023
Accepted: 27 December 2023
First Online: 20 January 2024
Declarations
:
: Dr. Garg is an advisor for AbbVie, Aclaris Therapeutics, Anaptys Bio, Aristea Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Cosmo Pharma, Incyte, Insmed, Janssen, Novartis, Pfizer, Sonoma Biotherapeutics, UCB, Union Therapeutics, Ventyx Biosciences, and Viela Biosciences, and receives honoraria. Dr Garg receives research grants from AbbVie, UCB, National Psoriasis Foundation, and CHORD COUSIN Collaboration (C3). He is the co-copyright holder of the HS-IGA and HiSQOL instruments. Dr Ingram receives a stipend as Editor-in-Chief of the British Journal of Dermatology and an authorship honorarium from UpToDate. He is a consultant for Abbvie, Boehringer Ingelheim, ChemoCentryx, Citryll, Novartis, UCB Pharma, and UNION Therapeutics and has served on advisory boards for Insmed, Kymera Therapeutics, and Viela Bio. He is the co-copyright holder of HiSQOL and Investigator Global Assessment instruments for HS. His department receives income from copyright of the Dermatology Life Quality Instrument (DLQI) and related instruments. He is the Treasurer of the CHORD-COUSIN Collaboration (C3).
